Michael Rice, SVP and Head of Advanced Therapeutics, recently presented at the 2026 Muscular Dystrophy Association (MDA) Conference in Orlando. His session, “Beyond the Science: Navigating Today’s Drug Development Climate,” took place on Tuesday, March 10, 2026.
Download the presentation to learn how today’s investment and regulatory environment is reshaping the neurology pipeline; including which mechanisms and modalities are facing headwinds, where funding is flowing, and what’s driving pharma partnership activity.
